4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001604457-26-000005
CEO gave up 18,611 shares (to pay taxes)
- CEO acquired 63,475 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Walker Neal · CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-03 | Exercise or conversion : show line 1 in the form | +63,475 | 1,562,497 | D | ||
| 2026-02-03 | Shares withheld for taxes : show line 2 in the form | −18,611 | $3.47 | $64,580 | 1,543,886 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-03 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −63,475 | 190,425 | D |
Loading xslF345X05/form4-02052026_090254.xml…